BioDelivery Sciences to Present at the Cantor Fitzgerald Global Healthcare Conference and the Ladenburg Thalmann 2018 Healthcare Conference
Cantor Fitzgerald Global Healthcare Conference2018
Date: Monday, October 1, 2018
Presentation Time: 4:
05 PM Eastern Time
InterContinental New York Barclay Hotel, New York City, NY
Ladenburg Thalmann 2018 Healthcare Conference
Date: Tuesday, October 2, 2018
Presentation Time: 3:00 PM Eastern Time
Location: Sofitel New York, New York City, NY
The presentations will be webcast live and can be accessed at www.bdsi.com. For those who are not available to listen to the live broadcast, replay of the webcasts will be available on the BDSI website.
BDSI's marketed products and those in development address serious and debilitating conditions such as breakthrough cancer pain, chronic pain and opioid dependence. BDSI's headquarters is in Raleigh, North Carolina.
For more information, please visit or follow us:
BUNAVAIL® (buprenorphine and naloxone) buccal film (CIII) and BELBUCA® (buprenorphine) buccal film (CIII) are marketed in the U.S. by BioDelivery Sciences. For full prescribing information and important safety information on BDSI products please visit www.bdsi.com where the Company promptly posts press releases, SEC filings and other important information or contact the Company at (800) 469-0261. For full prescribing and safety information on BELBUCA, please visit www.belbuca.com and for full prescribing and safety information on BUNAVAIL, please visit www.bunavail.com.
Vice President, Investor and Public Relations
Source: BioDelivery Sciences International, Inc.